Seven new option listings and one option delisting on July 10th
PremiumThe FlySeven new option listings and one option delisting on July 10th
4M ago
Silence Therapeutics price target raised to $55 from $42 at Chardan
Premium
The Fly
Silence Therapeutics price target raised to $55 from $42 at Chardan
4M ago
Silence Therapeutics price target raised to $49 from $45 at Morgan Stanley
Premium
The Fly
Silence Therapeutics price target raised to $49 from $45 at Morgan Stanley
4M ago
Silence Therapeutics’ Zerlasiran Shows Promising Results
PremiumCompany AnnouncementsSilence Therapeutics’ Zerlasiran Shows Promising Results
5M ago
Silence Therapeutics announces 48-week data from Phase 2 study of zerlasiran
Premium
The Fly
Silence Therapeutics announces 48-week data from Phase 2 study of zerlasiran
5M ago
Silence Therapeutics Shareholders Approve Resolutions
Premium
Company Announcements
Silence Therapeutics Shareholders Approve Resolutions
6M ago
Silence Therapeutics Board Veteran Retires
PremiumCompany AnnouncementsSilence Therapeutics Board Veteran Retires
6M ago
Silence Therapeutics Announces Upcoming AGM
Premium
Company Announcements
Silence Therapeutics Announces Upcoming AGM
7M ago
Silence Therapeutics says additional results from APOLLO phase 1 study published
Premium
The Fly
Silence Therapeutics says additional results from APOLLO phase 1 study published
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100